Misplaced Pages

Asphyxiating thoracic dysplasia

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Asphyxiating thoracic dysplasia 3) Medical condition
Asphyxiating thoracic dysplasia
Other namesJeune syndrome, asphyxiating thoracic chondrodystrophy, infantile thoracic dystrophy
CXR of a newborn with asphyxiating thoracic dysplasia. Note the short ribs.
SpecialtyMedical genetics Edit this on Wikidata
SymptomsNarrow chest, short ribs, shortened bones of the arms and legs, unusually shaped pelvis, and extra fingers and/or toes
TreatmentMechanical ventilation, endotracheal suctioning, postural drainage, Vertical expandable prosthetic titanium rib (VEPTR), Lateral thoracic expansion, or other chest reconstruction surgeries.
Frequency1 in 100,000 to 130,000
DeathsMortality of affected: 60-70%

Asphyxiating thoracic dysplasia (ATD), also known as Jeune syndrome, is a rare inherited bone growth disorder (autosomal recessive skeletal dysplasia) that primarily affects the thoracic region. It was first described in 1955 by the French pediatrician Mathis Jeune. Common signs and symptoms can include a narrow chest, short ribs, shortened bones in the arms and legs, short stature, and extra fingers and toes (polydactyly). The restricted growth and expansion of the lungs caused by this disorder results in life-threatening breathing difficulties; occurring in 1 in every 100,000-130,000 live births in the United States.

People who are affected with this disorder live short lives either only into infancy or early childhood. If they live beyond childhood, breathing problems can improve with age, but there is a possibility of developing severe kidney or heart problems. Several mutations in different genes such as  IFT80, DYNC2H1, WDR19, IFT140 and TTC21B have been identified in some families with the condition as possible causes of the disorder. Treatment is based on the signs and symptoms present in each person.

Types

Type OMIM Gene Locus
ATD1 208500 ? 15q13
ATD2 611263 IFT80 3q
ATD3 613091 DYNC2H1 11q

Signs and symptoms

Lateral CXR of the same person above

Jeune syndrome is a rare genetic disorder that affects the way a child's cartilage and bones develop. It begins before the child is born and primarily affects the child's rib cage, pelvis, arms and legs. Usually, problems with the rib cage cause the most serious health problems for children with Jeune syndrome. Their rib cages (thorax) are smaller and narrower than usual, which inhibits the child's lungs from developing fully or expanding when they inhale. The child may breathe rapidly and shallowly. They may have trouble breathing when they have an upper or lower respiratory infection, like pneumonia. Breathing trouble can range from mild to severe. In some children, it is not noticeable, aside from fast breathing; however, in others, breathing problems can be fatal. About 60% to 70% of children with this condition die from respiratory failure as babies or young children. Children with Jeune syndrome who survive often develop problems with their kidneys, and over time they may experience kidney failure. As a result, few children with Jeune syndrome live into their teen years. Children with Jeune syndrome have a form of dwarfism. They are short in stature, and their arms and legs are shorter than most people's.

Diagnosis

Jeune syndrome is a rare autosomal recessive ciliopathy. This diagnosis is grouped with other chest problems called thoracic insufficiency syndrome (TIS). Diagnosis of Jeune syndrome can be made as early as before birth if signs and symptoms are apparent on an ultrasound; however, diagnosis after birth usually occurs through X-rays and genetic testing, such as the tests found on the Genetic Testing Registry (GTR).

Treatment

Medical care

In order to help relieve respiratory distress, mechanical ventilation is required in most severe cases; while pulmonary infections that tend to lead to respiratory failure occur in less severe cases. In order to treat these infections, doctors may suggest antibiotics, endotracheal suctioning, or postural drainage.

Surgical care

In severe cases, surgical action is needed; otherwise, failure to intervene can result in pulmonary damage and eventual fatality. Vertical expandable prosthetic titanium rib (VEPTR) surgery is the most common treatment for severe chest wall deformities. During this procedure, one or more titanium rods are attached to the ribs near the spine, which allow space for the patient's lungs to develop. Small adjustments are made every four to six months through a small incision in the patient's back. Alternatively, lateral thoracic expansion is used to enlarge the chest wall by separating the ribs from their periosteum and covering them with titanium struts. This procedure is common among patients older than a year due to its safe and effective outcome. Chest reconstruction is another surgical procedure that promotes thoracic cage growth. It can be done as an enlargement of the thoracic cage by sternotomy and fixation with bone grafts, or a methylmethacrylate prostheses plate.

References

  1. ^ Kondo, Hiroaki; Hyuga, Shunsuke; Fujita, Tomoe; Adachi, Mariko; Mochizuki, Junko; Okutomi, Toshiyuki (2021-02-11). "First Report of Spinal Anesthesia for Cesarean Delivery in a Parturient With Jeune Syndrome: A Case Report". A&A Practice. 15 (2): e01400. doi:10.1213/XAA.0000000000001400. ISSN 2575-3126. PMID 33577174. S2CID 231898002.
  2. ^ de Vries J, Yntema JL, van Die CE, Crama N, Cornelissen EA, Hamel BC (January 2010). "Jeune syndrome: description of 13 cases and a proposal for follow-up protocol". European Journal of Pediatrics. 169 (1): 77–88. doi:10.1007/s00431-009-0991-3. PMC 2776156. PMID 19430947.
  3. Saletti D, Grigio TR, Tonelli D, Ribeiro Júnior OD, Marini F. Case report: anesthesia in patients with asphyxiating thoracic dys-trophy: Jeune syndrome. Rev Bras Anestesiol. 2012;62:424–431.
  4. "Jeune syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2019-11-14.
  5. Reference, Genetics Home. "Asphyxiating thoracic dystrophy". Genetics Home Reference. Retrieved 2019-11-14.
  6. Jeune M, Beraud C, Carron R (1955). "". Archives Françaises de Pédiatrie (in French). 12 (8): 886–91. ISSN 0003-9764. PMID 13292988.
  7. ^ Zanelli, Santina A (2024-02-02). "Asphyxiating Thoracic Dystrophy (Jeune Syndrome) Treatment & Management: Approach Considerations, Medical Care, Surgical Care". Medscape Reference. Retrieved 2024-06-29.
  8. Bianchi, Diana W.; Crombleholme, Timothy M.; D'Alton, Mary E. (2000). Fetology: Diagnosis & Management of the Fetal Patient. McGraw Hill Professional. ISBN 9780838525708.
  9. Mayer, Oscar Henry (June 2009). "Management of thoracic insufficiency syndrome". Current Opinion in Pediatrics. 21 (3): 333–343. doi:10.1097/mop.0b013e328329a500. ISSN 1040-8703.
  10. Philadelphia, The Children's Hospital of (2018-07-31). "Jeune Syndrome". www.chop.edu. Retrieved 2019-11-14.

External links

ClassificationD
External resources
Diseases of cilia
Structural
Signaling
Other/ungrouped
See also: ciliary proteins
Cytoskeletal defects
Microfilaments
Myofilament
Actin
Myosin
Troponin
Tropomyosin
Titin
Other
IF
1/2
3
4
5
Microtubules
Kinesin
Dynein
Other
Membrane

Ankyrin: Long QT syndrome 4

Catenin
Other
Related topics: Cytoskeletal proteins
Categories: